„First Line“

Suchergebnisse

3.416 Treffer

• Phase I/II Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: North Central Cancer Treatment Group Trial N0745 (Alliance)
  Hubbard, Joleen M. ; Mahoney, Michelle R. ; Loui, William S. ; Roberts, Lewis R. ; Smyrk, Thomas C. ; Gatalica, Zoran ; Borad, Mitesh ; Kumar, Shaji ; Alberts, Steven R.
• Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole as First-Line Treatment for Invasive Aspergillosis
  Harrington, Rachel ; Lee, Edward ; Yang, Hongbo ; Wei, Jin ; Messali, Andrew ; Azie, Nkechi ; Wu, Eric Q. ; Spalding, James
• Cognitive dysfunction in patients with multiple sclerosis treated with first-line disease-modifying therapy: a multi-center, controlled study using the BICAMS battery
  Cinar, Bilge Piri ; Kösehasanoğulları, Görkem ; Yigit, Pinar ; Ozakbas, Serkan
• G-CSF use in patients receiving first-line chemotherapy for non-Hodgkin’s lymphoma (NHL) and granulocyte-colony stimulating factors (G-CSF) as observed in clinical practice in Italy
  Vitolo, Umberto ; Angrili, Francesco ; DeCosta, Lucy ; Wetten, Sally ; Federico, Massimo
• Is There an Indication for First Line Radiotherapy in Primary CNS Lymphoma?
  Seidel, Clemens ; Viehweger, Christine ; Kortmann, Rolf-Dieter 2023 Universitätsbibliothek Leipzig
• Factors affecting prognosis in patients treated with bevacizumab plus paclitaxel as first-line chemotherapy for HER2-negative metastatic breast cancer: an international pooled analysis of individual patient data from four prospective observational studies
  Yamamoto, Yutaka ; Yamashiro, Hiroyasu ; Schneeweiss, Andreas ; Müller, Volkmar ; Gluz, Oleg ; Klare, Peter ; Aktaş, Bahriye ; Magdolna, Dank ; Büdi, László ; Pikó, Béla ; Mangel, László ; Toi, Masakazu ; Morita, Satoshi ; Ohno, Shinji
• Prognostic impact of rapid reduction of involved free light chains in multiple myeloma patients under first-line treatment with Bendamustine, Prednisone, and Bortezomib (BPV)
  Holzhey, Tanja ; Pönisch, Wolfram ; Wang, Song-Yau ; Holzvogt, Madlen ; Holzvogt, Bruno ; Andrea, Marc ; Zehrfeld, Thomas ; Hammerschmidt, Doreen ; Hoffmann, Franz Albert ; Becker, Cornelia ; Schwarzer, Andreas ; Schwarz, Maik ; Schönfelder-Fricke, Uta ; Edelmann, Thomas ; Braunert, Leanthe ; Franke, Georg-Nikolaus ; Jentzsch, Barbara Madlen ; Schwind, Sebastian ; Bill, Markus ; Grimm, Juliane ; Remane, Yvonne ; Platzbecker, Uwe ; Scholz, Markus
• Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRASmetastatic colorectal cancer: final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)
  Fernandez-Plana, Julen ; Pericay, Carlos ; Quintero, Guillermo ; Alonso, Vicente ; Salud, Antonieta ; Méndez M., Miguel ; Salgado, Mercedes ; Saigi, Eugeni ; Cirera, Luis
• Peripheral blood lymphocyte/monocyte ratio following completion of first-line therapy predicts early relapse in patients with diffuse large B cell lymphoma
  Zhou, Shu-Juan ; Ma, Yong-Yong ; Zhang, Yu ; Luo, Sheng ; Tang, Li-Yuan ; Chen, Yi ; Sun, Lan ; Yu, Kang
• Mechanisms of first-line antimicrobial resistance in multi-drug and extensively drug resistant strains of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa
  Dookie, Navisha ; Sturm, A. Willem ; Moodley, Prashini
• Capecitabine in Combination with Docetaxel in First Line in HER2-Negative Metastatic Breast Cancer: an Observational Study
  Kószó, Renáta ; Sántha, Dóra ; Büdi, László ; Erfán, József ; Győrfy, Károly ; Horváth, Zsolt ; Kocsis, Judit ; Landherr, László ; Hitre, Erika ; Mahr, Károly ; Pajkos, Gábor ; Pápai, Zsuzsanna ; Kahan, Zsuzsanna
• Brain structure and function in patients with ovarian cancer treated with first-line chemotherapy: a pilot study
  Correa, D. D. ; ROOT, J. C. ; Kryza-Lacombe, M. ; Mehta, M. ; Karimi, S. ; Hensley, M. L. ; Relkin, N.
• Efficacy and safety of abacavir-containing combination antiretroviral therapy as first-line treatment of HIV infected children and adolescents: a systematic review and meta-analysis
  Adetokunboh, Olatunji O. ; Schoonees, Anel ; Balogun, Tolulope A. ; Wiysonge, Charles S.
• The potential of a multiplex high-throughput molecular assay for early detection of first and second line tuberculosis drug resistance mutations to improve infection control and reduce costs: a decision analytical modeling study
  van’t Hoog, AH ; Bergval, I. ; Tukvadze, N. ; Sengstake, S. ; Aspindzelashvili, R. ; Anthony, RM ; Cobelens, F.
• Survival outcomes for first-line antiretroviral therapy in India’s ART program
  Dandona, Rakhi ; Rewari, Bharat B. ; Kumar, G. Anil ; Tanwar, Sukarma ; Kumar, S. G. Prem ; Vishnumolakala, Venkata S. ; Duber, Herbert C. ; Gakidou, Emmanuela ; Dandona, Lalit
• SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase III trial
  Rochlitz, Christoph ; Bigler, Martin ; von Moos, Roger ; Bernhard, Jürg ; Matter-Walstra, Klazien ; Wicki, Andreas ; Zaman, Khalil ; Anchisi, Sandro ; Küng, Marc ; Na, Kyung-Jae ; Bärtschi, Daniela ; Borner, Markus ; Rordorf, Tamara ; Rauch, Daniel ; Müller, Andreas ; Ruhstaller, Thomas ; Vetter, Marcus ; Trojan, Andreas ; Hasler-Strub, Ursula ; Cathomas, Richard ; Winterhalder, Ralph
• Comparison of Eylea® with Lucentis® as first-line therapy in patients with treatment-naïve neovascular age-related macular degeneration in real-life clinical practice: retrospective case-series analysis
  Böhni, Sophie C. ; Bittner, Mario ; Howell, Jeremy P. ; Bachmann, Lucas M. ; Faes, Livia ; Schmid, Martin K.
• Capecitabine in combination with either cisplatin or weekly paclitaxel as a first-line treatment for metastatic esophageal squamous cell carcinoma: a randomized phase II study
  Lee, Su Jin ; Kim, Sungmin ; Kim, Moonjin ; Lee, Jeeyun ; Park, Yeon Hee ; Im, Young-Hyuck ; Park, Se Hoon
• Does anti-p53 antibody status predict for clinical outcomes in metastatic colorectal cancer patients treated with fluoropyrimidine, oxaliplatin, plus bevacizumab as first-line chemotherapy?
  Osumi, Hiroki ; Shinozaki, Eiji ; Suenaga, Mitsukuni ; Kumekawa, Yosuke ; Ogura, Mariko ; Ozaka, Masato ; Matsusaka, Satoshi ; Chin, Keisho ; Yamamoto, Noriko ; Mizunuma, Nobuyuki
• Multicenter Phase II study of FOLFOX or biweekly XELOX and Erbitux (cetuximab) as first-line therapy in patients with wild-type KRAS/BRAF metastatic colorectal cancer: The FLEET study
  Soda, Hitoshi ; Maeda, Hiromichi ; Hasegawa, Junichi ; Takahashi, Takao ; Hazama, Shoichi ; Fukunaga, Mutsumi ; Kono, Emiko ; Kotaka, Masahito ; Sakamoto, Junichi ; Nagata, Naoki ; Oba, Koji ; Mishima, Hideyuki